ODC1 and central nervous system cancer: In 2001, Ernestus and colleagues identified ornithine decarboxylase activity as a marker of brain tumor malignancy; ornithine decarboxylase activity was notably greater in gliomas and increased with tumor severity, although polyamine concentrations did not consistently correlate with the degree of malignancy in their study of 670 patients [16].